What are the risks of sphincteroplasty in low transsphincteric fistulotomy sites for a patient with a history of anal fistula disease, particularly in terms of sensation and continence?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sphincteroplasty in Low Transsphincteric Fistulotomy Sites: Risks and Outcomes

Immediate sphincteroplasty following fistulotomy for low transsphincteric fistulas is a safe and effective approach that achieves 84-96% healing rates while maintaining continence in most patients, with only 10-20% experiencing minor continence disturbances and approximately 12% developing post-defecation soiling. 1, 2, 3

Continence and Sensation Risks

Overall Continence Profile

  • Simple fistulotomy without reconstruction carries a 10-20% risk of continence disturbances, which are typically minor and manageable 4, 5
  • When immediate sphincteroplasty is performed at the time of fistulotomy, the risk profile remains similar or potentially improved compared to fistulotomy alone 1, 2
  • Post-defecation soiling represents the most common continence issue, occurring in approximately 11.6% of patients with no baseline incontinence 2
  • Major fecal incontinence after fistulotomy with immediate sphincteroplasty occurs at very low rates in long-term follow-up 2, 3

Risk Stratification by Patient Factors

  • High transsphincteric fistulas show a 4-fold increased risk of incontinence compared to low fistulas (OR 4.0,95% CI 1.22-13.06), with one in five patients experiencing continence deterioration 3
  • Patients with prior fistulotomy history have a 5-fold increased probability of impaired continence (RR 5.00,95% CI 1.45-17.27), making this an absolute contraindication to repeat fistulotomy 2, 4
  • Male sex and recurrent fistulas may have a protective effect against postoperative incontinence, though larger studies are needed to confirm this finding 3
  • Female patients with anterior fistulas should never undergo fistulotomy due to asymmetrical anatomy and short anterior sphincter 4, 6

Anatomical Outcomes

Healing Rates

  • Fistulotomy with immediate sphincteroplasty achieves overall healing rates of 84-96% in long-term follow-up 1, 2, 3
  • Primary fistulas heal in 82.9% of cases, while recurrent fistulas heal in 86.5% of cases 3
  • High transsphincteric tracts heal in 83.8% of cases, and non-high fistulas heal in 84.3% 3
  • The technique provides rapid wound healing and avoids anal canal deformity or mucosal flap ectropion 7

Comparative Outcomes

  • Fistulotomy with primary sphincter repair demonstrates comparable healing rates to fistulotomy alone (93.3% vs 90.6%), without increased risk of septic complications (6.7% vs 3.7%) 1
  • This holds true even when sphincteroplasty is performed in higher-risk patients with multiple fistulas (26.7% vs 6.5%) and complex fistulas (37.8% vs 10.3%) 1
  • At mean follow-up of 29.4 months, success rates reach 95.8%, with fistula recurrence occurring in only 4.2% of patients 2

Long-Term Functional Results

  • Cleveland Clinic fecal incontinence scores do not change significantly after fistulotomy with immediate sphincteroplasty 2
  • At median follow-up of 96 months (range 84-204 months), 95% of patients maintain perfect anatomic and clinical functional results 7, 3
  • The technique avoids continence disturbance from sphincter division that would occur with fistulotomy alone 7

Critical Contraindications

Absolute Contraindications to Fistulotomy (With or Without Sphincteroplasty)

  • Anterior fistulas in female patients must never undergo fistulotomy due to asymmetrical anatomy and short anterior sphincter 4, 6
  • Prior fistulotomy history is an absolute contraindication—these patients require sphincter-preserving approaches to prevent catastrophic incontinence 4, 5
  • Active proctitis contraindicates fistulotomy 4, 6
  • In Crohn's disease, CDAI greater than 150 or evidence of perineal Crohn's involvement contraindicates fistulotomy 4

Alternative Sphincter-Preserving Approaches When Sphincteroplasty is Not Appropriate

Seton Drainage

  • Initial loose non-cutting seton placement can achieve fistula closure in 13.6-100% of cases and may serve as definitive treatment 4, 6
  • The seton should run through the sphincter complex ending in the internal opening to maintain drainage and prevent abscess recurrence 4, 5
  • Cutting setons should never be used—they result in a 57% incontinence rate from progressive sphincter transection 4, 5
  • Seton drainage allows inflammation to subside and can be curative without requiring definitive surgery 4, 5

LIFT Procedure

  • LIFT (ligation of intersphincteric fistula tract) can be considered as second-line treatment if seton drainage fails 4, 6
  • LIFT achieved 82% primary healing in low transsphincteric fistulas without affecting fecal continence 8
  • In the 18% without primary healing, the transsphincteric fistula was converted to an intersphincteric fistula, allowing subsequent fistulotomy with preservation of the external anal sphincter and achieving 100% overall healing 8
  • However, real-world practice shows LIFT carries a 41-59% failure rate 4, 6

Common Pitfalls to Avoid

Intraoperative Errors

  • Aggressive probing to define the tract causes iatrogenic complications and should be avoided 4, 5
  • Aggressive dilation causes permanent sphincter injury and must not be performed 4, 5
  • The assumption that "low" transsphincteric fistulas are safe for fistulotomy is incorrect—any transsphincteric fistula involves sphincter muscle and requires careful patient selection 4, 5

Strategic Errors

  • Rushing to definitive surgery should be avoided—seton drainage alone can be curative and allows inflammation to subside 4, 5
  • Performing fistulotomy in patients with compromised anal sphincters risks catastrophic incontinence 8
  • Failing to recognize absolute contraindications (anterior fistulas in females, prior fistulotomy, active proctitis) leads to poor outcomes 4, 6

Treatment Algorithm for Low Transsphincteric Fistulas

Step 1: Rule Out Absolute Contraindications

  • Anterior fistula in females 4, 6
  • Prior fistulotomy history 4, 5
  • Active proctitis 4, 6
  • Crohn's disease with CDAI >150 or perineal involvement 4

Step 2: Risk Stratification

  • For suitable candidates without contraindications: fistulotomy with immediate sphincteroplasty provides definitive cure with acceptable 10-20% minor continence risk and 84-96% healing rates 4, 1, 2, 3
  • For high-risk patients (prior surgery, female anterior fistulas, compromised sphincters): initial loose seton placement with consideration for LIFT if seton fails 4, 6, 5

Step 3: Postoperative Monitoring

  • Follow-up at 1 week, 1 month, 3 months, and 1 year to assess healing and continence 2
  • Median time to fistula recurrence when it occurs is 17.3 months (range 6-26 months) 2
  • Long-term follow-up shows sustained results at median 96 months 3

References

Guideline

Risks and Outcomes of Low Transsphincteric Fistulotomy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Low Transsphincteric Fistulas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Fistulotomy vs LIFT for Transsphincteric Fistulas

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Ligation of the intersphincteric fistula tract in low transsphincteric fistulae: a new technique to avoid fistulotomy.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2013

Related Questions

What are the risks and anatomical outcomes of low trans fistulotomy sites in patients with a history of anal fistula disease, particularly in terms of sensation and continence?
What are the risks of sphincteroplasty in terms of sensation and continence in a patient with a history of low transsphincteric fistulotomy?
Can an external anal sphincter (EAS) be trained to squeeze closer to baseline function before a fistulotomy is performed with pelvic therapy in a patient with a history of failed LIFT procedure, incontinence, and difficulty maintaining perineal hygiene?
Can fistulotomy tissue in a bisexual male with a history of low transanal fistulotomy, currently undergoing biofeedback therapy and pelvic floor exercises, become stronger over time and less likely to reform as a fistula, even with anal sex, if given adequate time to heal?
What is the best course of action for an adult patient with a history of anorectal surgery and a previously successfully treated fistula with fistulotomy 6 months ago, now presenting with a new fistula?
What is the role of MRI in a young to middle-aged adult from an area with poor sanitation, presenting with psychosis associated with typhoid fever, and recent travel history to endemic areas or exposure to contaminated food or water?
What are the risk factors for colorectal cancer in individuals, particularly those over 50 with a family history or genetic predisposition?
What are the possible causes of vaginal bleeding in women of different ages and reproductive stages?
What is the best treatment approach for a pregnant patient with Deep Vein Thrombosis (DVT)?
What tests are used to diagnose asthma in children?
What is the recommended treatment for a patient with aspiration pneumonia, including antibiotic therapy and supportive care?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.